-
1
-
-
84872205037
-
-
Available at: Accessed 05 September 2007
-
National Psoriasis Foundation. About psoriasis. Available at: http://www.psoriasis.org/about/faq. Accessed 05 September 2007.
-
About Psoriasis
-
-
-
2
-
-
0142151699
-
AAD consensus statement on psoriasis therapies
-
DOI 10.1016/S0190-9622(03)01870-X
-
Callen JP, Krueger GG, Lebwohl M, et al. AAD consensus statement on psoriasis therapies. J Am Acad Dermatol. 2003;49:897-899. (Pubitemid 37314880)
-
(2003)
Journal of the American Academy of Dermatology
, vol.49
, Issue.5
, pp. 897-899
-
-
Callen, J.P.1
Krueger, G.G.2
Lebwohl, M.3
McBurney, E.I.4
Mease, P.5
Menter, A.6
Paller, A.S.7
Pariser, D.M.8
Weinblatt, M.9
Zimmerman, G.10
-
3
-
-
14244258610
-
Psoriasis pathophysiology: Current concepts of pathogenesis
-
Krueger JG, Bowcock A. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis. 2005;64:ii30-ii36.
-
(2005)
Ann Rheum Dis
, vol.64
-
-
Krueger, J.G.1
Bowcock, A.2
-
4
-
-
25444469167
-
Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis
-
DOI 10.1080/09546630510041060
-
Lowe N, Feldman SR, Sherer D, et al. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. J Dermatolog Treat. 2005;16(3):158-164. (Pubitemid 41364775)
-
(2005)
Journal of Dermatological Treatment
, vol.16
, Issue.3
, pp. 158-164
-
-
Lowe, N.1
Feldman, S.R.2
Sherer, D.3
Weiss, J.4
Shavin, J.S.5
Lin, Y.L.6
Foley, V.7
Soto, P.8
-
5
-
-
80053006170
-
-
Available at Accessed 26 September 2007
-
Temovate prescribing information. Available at: http://www.pharmaderm. com/pdf/Temovate-pi-cream.pdf. Accessed 26 September 2007.
-
Temovate Prescribing Information
-
-
-
6
-
-
80052994987
-
-
Available at Accessed 26 September 2007
-
Ultravate prescribing information. Available at: http://packageinserts. bms.com/pi/pi-ultravate-cream.pdf. Accessed 26 September 2007.
-
Ultravate Prescribing Information
-
-
-
7
-
-
80053016688
-
-
Available at: Accessed 26 September 2007
-
Vanos prescribing information. Available at: http://www.medicis.com/ products/pi/pi-vanos.pdf. Accessed 26 September 2007.
-
Vanos Prescribing Information
-
-
-
8
-
-
25144518209
-
Vanos (fluocinonide cream, 0.1%)
-
Abramovits W, Gupta AK. Vanos (fluocinonide cream, 0.1%). Skinmed. 2005;4:239-240.
-
(2005)
Skinmed
, vol.4
, pp. 239-240
-
-
Abramovits, W.1
Gupta, A.K.2
-
9
-
-
0033021230
-
Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin
-
DOI 10.1023/A:1018890422825
-
Schwarb FP, Imanidis G, Smith EW, et al. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin. Pharm Res. 1999;16(6):909-915. (Pubitemid 29284204)
-
(1999)
Pharmaceutical Research
, vol.16
, Issue.6
, pp. 909-915
-
-
Schwarb, F.P.1
Imanidis, G.2
Smith, E.W.3
Haigh, J.M.4
Surber, C.5
-
10
-
-
33845691405
-
An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis
-
DOI 10.1001/archderm.142.12.1568
-
Schlessinger J, Miller B, Gilbert RD, et al. An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis. Arch Dermatol. 2006;142(12):1568-1572. (Pubitemid 44969212)
-
(2006)
Archives of Dermatology
, vol.142
, Issue.12
, pp. 1568-1572
-
-
Schlessinger, J.1
Miller, B.2
Gilbert, R.D.3
Plott, R.T.4
-
11
-
-
0021932112
-
Clobetasol propionate versus fluocinonide creams in psoriasis and eczema
-
Jegasothy B, Jacobson C, Levine N, et al. Clobetasol propionate versus fluocinonide creams in psoriasis and eczema. Int J Dermatol. 1985;24(7):461-465. (Pubitemid 15246727)
-
(1985)
International Journal of Dermatology
, vol.24
, Issue.7
, pp. 461-465
-
-
Jegasothy, B.1
Jacobson, C.2
Levine, N.3
-
12
-
-
0031901416
-
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis
-
DOI 10.1016/S0190-9622(98)70594-8
-
Lebwohl M, Ast E, Callen JP, et al. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. J Am Acad Dermatol. 1998;38(5 Pt 1):705-711. (Pubitemid 28213714)
-
(1998)
Journal of the American Academy of Dermatology
, vol.38
, Issue.5 I
, pp. 705-711
-
-
Lebwohl, M.1
Ast, E.2
Callen, J.P.3
Cullen, S.I.4
Hong, S.R.5
Kulp-Shorten, C.L.6
Lowe, N.J.7
Phillips, T.J.8
Rosen, T.9
Wolf, D.I.10
Quell, J.M.11
Sefton, J.12
Lue, J.C.13
Gibson, J.R.14
Chandraratna, R.A.S.15
-
14
-
-
0030076244
-
Comparison of cosmetic and physicochemical properties of six topical corticosteroid creams
-
Hadzija BW, Ambrose WW. Comparison of cosmetic and physicochemical properties of six topical corticosteroid creams. Cutis. 1996;57(2 Suppl):13-8.
-
(1996)
Cutis
, vol.57
, Issue.2 SUPPL.
, pp. 13-18
-
-
Hadzija, B.W.1
Ambrose, W.W.2
-
15
-
-
42949094755
-
In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle
-
Gans EH, Sadiq I, Stoudemayer T, et al. In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle. J Drugs Dermatol. 2008;7(1):28-32.
-
(2008)
J Drugs Dermatol
, vol.7
, Issue.1
, pp. 28-32
-
-
Gans, E.H.1
Sadiq, I.2
Stoudemayer, T.3
-
16
-
-
0015265248
-
The psoriasis bioassay for topical corticosteroid activity
-
Dumas KJ, Scholtz JR. The psoriasis bioassay for topical corticosteroid activity. Acta Derm Venereol. 1972;52(1):43-48.
-
(1972)
Acta Derm Venereol
, vol.52
, Issue.1
, pp. 43-48
-
-
Dumas, K.J.1
Scholtz, J.R.2
-
18
-
-
0001861697
-
Chapter 242: Principles of Topical Therapy
-
Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S, eds. 5th Ed. New York, NY:McGraw-Hill
-
Shupack JL, Washenik K, Pak GH. Chapter 242: Principles of Topical Therapy. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S, eds. Fitzpatrick's Dermatology in General Medicine. 5th Ed. New York, NY:McGraw-Hill; 1999:2702-2712.
-
(1999)
Fitzpatrick's Dermatology in General Medicine
, pp. 2702-2712
-
-
Shupack, J.L.1
Washenik, K.2
Pak, G.H.3
-
19
-
-
34247565553
-
The effect of adhesive dressing edges on cutaneous irritancy and skin barrier function
-
Dykes PJ. The effect of adhesive dressing edges on cutaneous irritancy and skin barrier function. J Wound Care. 2007;16(3):97-100.
-
(2007)
J Wound Care
, vol.16
, Issue.3
, pp. 97-100
-
-
Dykes, P.J.1
|